Please ensure Javascript is enabled for purposes of website accessibility
Inicio > Productos > Anticuerpos > Biosimilares

Anti-Human PD-L1 & TGF-beta RII Reference Antibody (Retlirafusp Alfa, RUO) (HV974406)

Anti-Human PD-L1 & TGF-beta RII Reference Antibody (Retlirafusp Alfa, RUO)
Anti-Human PD-L1 & TGF-beta RII Reference Antibody (Retlirafusp Alfa, RUO)
Anti-Human PD-L1 & TGF-beta RII Reference Antibody (Retlirafusp Alfa, RUO)
Anti-Human PD-L1 & TGF-beta RII Reference Antibody (Retlirafusp Alfa, RUO)
Anti-Human PD-L1 & TGF-beta RII Reference Antibody (Retlirafusp Alfa, RUO)
Anti-Human PD-L1 & TGF-beta RII Reference Antibody (Retlirafusp Alfa, RUO)
Precio(USD):
Especificación:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
Número:
Contáctenos
  • Vista general

  • Imágenes

  • Referencias

  • Datasheet

  • SDS

Vista general
Número de catálogoHV974406
Reactividad de especiesHuman
AplicacionesELISA, Bioactivity: FCM, Functional assay, Research in vivo, WB
Especie huéspedHuman
ClonalidadMonoclonal
IsotipoIgG4-kappa
Actividad biológica SHR-1701 (10 ug/mL) can inhibit TGF-β signaling pathway, activate PI3K/Akt/Erk signaling pathway, rescue lymphocytes and restore the anti-tumor function of peripheral blood CD8 + T cells in patients with lung cancer [1].
Aplicaciones probadas WB
Objetivo B7 homolog 1, B7-H1, B7H1, CD274, PD-L1, PDCD1 ligand 1, PDCD1L1, PDCD1LG1, PDL1, Programmed cell death 1 ligand 1, Programmed death ligand 1, EC:2.7.11.30, TGF-beta receptor type II, TGF-beta receptor type-2, TGF-beta type II receptor, TGFBR2, TGFR-2, TbetaR-II, Transforming growth factor-beta receptor type II
Nivel de endotoxinas < 10 EU/mg
Pureza >95% as determined by SDS-PAGE.
Purificación Protein A/G purified from cell culture supernatant.
Número de acceso Q9NZQ7 & P37173
Forma Liquid
Buffer de almacenamiento 0.01M PBS pH 7.4.

Consulte la información específica del buffer en la copia impresa del datasheet o en el COA específico del lote.

Información de uso del producto
Aplicación Dilución
WB 1:500-1:2000
Estabilidad y almacenamiento Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Nombres alternativosSHR-1701
Referencias 1. Bo Cheng, et al. Anti-PD-L1/TGF-βR fusion protein (SHR-1701) overcomes disrupted lymphocyte recovery-induced resistance to PD-1/PD-L1 inhibitors in lung cancer. Cancer Commun (Lond). 2022 Jan;42(1):17-36. [HV974406]
Nota For research use only. Not suitable for clinical or therapeutic use.
Imágenes
  • Anti-Human PD-L1 & TGF-beta RII Reference Antibody (Retlirafusp Alfa, RUO)

    SDS-PAGE

    SDS-PAGE for Research Grade Retlirafusp Alfa.

  • Anti-Human PD-L1 & TGF-beta RII Reference Antibody (Retlirafusp Alfa, RUO)

    Bioactivity

    Detects recombinant PDL1 (Catalog No: HV974011) in indirect ELISA.

  • Anti-Human PD-L1 & TGF-beta RII Reference Antibody (Retlirafusp Alfa, RUO)

    Western blot

    Western blot analysis was performed using anti-PDL1 monoclonal antibody at 1ug/mL on various samples.
    Lane 1: recombinant human PDL1 (Catalog No: HV974011)
    Lane 2: Negative control

Referencias
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recomendación

Contáctenos para cotizaciones personalizadas, solicitudes en masa y cualquier otro problema.

Correo: [email protected]

Lista de distribuidores